Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature

被引:132
作者
Roberts, Megan C. [1 ]
Dotson, W. David [2 ]
DeVore, Christopher S. [3 ,4 ]
Bednar, Erica M. [5 ]
Bowen, Deborah J. [6 ]
Ganiats, Theodore G. [7 ]
Green, Ridgely Fisk [8 ,9 ]
Hurst, Georgia M.
Philp, Alisdair R. [10 ]
Ricker, Charite N. [11 ]
Sturm, Amy C. [12 ]
Trepanier, Angela M. [13 ]
Williams, Janet L. [12 ]
Zierhut, Heather A. [14 ]
Wilemon, Katherine A. [15 ]
Hampel, Heather [16 ,17 ]
机构
[1] Natl Canc Inst, Div Canc Control & Populat Sci, Rockville, MD 20850 USA
[2] Ctr Dis Control & Prevent CDC, Off Publ Hlth Genom, Atlanta, GA USA
[3] CDC, Off Publ Hlth Preparedness & Response, Atlanta, GA USA
[4] Emory Univ, Publ Hlth, Atlanta, GA 30322 USA
[5] Univ Texas MD Anderson Canc Ctr, Dept Clin Canc Genet & Canc Prevent & Control Pla, Houston, TX 77030 USA
[6] Univ Washington, Bioeth & Humanities, Seattle, WA 98195 USA
[7] Agcy Healthcare Res & Qual, Natl Ctr Excellence Primary Care Res, Rockville, MD USA
[8] Carter Consulting Inc, Atlanta, GA USA
[9] CDC, Off Publ Hlth Genom, Atlanta, GA USA
[10] Univ Kansas, Hosp & Clin Westwood, Lawrence, KS 66045 USA
[11] Univ Southern Calif, Los Angeles, CA USA
[12] Genom Med Inst, Danville, PA USA
[13] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA
[14] Univ Minnesota, Coll Biol Sci, Genet Cell Biol & Dev, Minneapolis, MN USA
[15] Familial Hypercholesterolemia Fdn, Pasadena, CA USA
[16] Ohio State Univ, Div Human Genet & Biospecimen Res, Columbus, OH 43210 USA
[17] Ohio State Univ, Internal Med, Comprehens Canc Ctr, Columbus, OH 43210 USA
关键词
COST-EFFECTIVENESS; FAMILIAL HYPERCHOLESTEROLEMIA; LYNCH SYNDROME; IMPLEMENTATION SCIENCE; COLORECTAL-CANCER; RELATIVES; TRIAL; DISSEMINATION; INDIVIDUALS; INFORMATION;
D O I
10.1377/hlthaff.2017.1630
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Cascade screening is the process of contacting relatives of people who have been diagnosed with certain hereditary conditions. Its purpose is to identify, inform, and manage those who are also at risk. We conducted a scoping review to obtain a broad overview of cascade screening interventions, facilitators and barriers to their use, relevant policy considerations, and future research needs. We searched for relevant peer-reviewed literature in the period 1990-2017 and reviewed 122 studies. Finally, we described 45 statutes and regulations related to the use and release of genetic information across the fifty states. We sought standardized best practices for optimizing cascade screening across various geographic and policy contexts, but we found none. Studies in which trained providers contacted relatives directly, rather than through probands (index patients), showed greater cascade screening uptake; however, policies in some states might limit this approach. Major barriers to cascade screening delivery include suboptimal communication between the proband and family and geographic barriers to obtaining genetic services. Few US studies examined interventions for cascade screening or used rigorous study designs such as randomized controlled trials. Moving forward, there remains an urgent need to conduct rigorous intervention studies on cascade screening in diverse US populations, while accounting for state policy considerations.
引用
收藏
页码:801 / 808
页数:8
相关论文
共 46 条
[1]  
[Anonymous], 2009, HIPAA PRIVACY RULE E
[2]   Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia [J].
Bernhardt, Barbara A. ;
Zayac, Cara ;
Pyeritz, Reed E. .
GENETICS IN MEDICINE, 2011, 13 (09) :812-820
[3]   Outcome of case finding among relatives of patients with known heterozygous familial hypercholesterolaemia [J].
Bhatnagar, D ;
Morgan, J ;
Siddiq, S ;
Mackness, MI ;
Miller, JP ;
Durrington, PN .
BRITISH MEDICAL JOURNAL, 2000, 321 (7275) :1497-1500A
[4]   Utilizing Remote Real-Time Videoconferencing to Expand Access to Cancer Genetic Services in Community Practices: A Multicenter Feasibility Study [J].
Bradbury, Angela ;
Patrick-Miller, Linda ;
Harris, Diana ;
Stevens, Evelyn ;
Egleston, Brian ;
Smith, Kyle ;
Mueller, Rebecca ;
Brandt, Amanda ;
Stopfer, Jill ;
Rauch, Shea ;
Forman, Andrea ;
Kim, Rebecca ;
Fetzer, Dominique ;
Fleisher, Linda ;
Daly, Mary ;
Domchek, Susan .
JOURNAL OF MEDICAL INTERNET RESEARCH, 2016, 18 (02)
[5]   Convergence of Implementation Science, Precision Medicine, and the Learning Health Care System A New Model for Biomedical Research [J].
Chambers, David A. ;
Feero, W. Gregory ;
Khoury, Muin J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (18) :1941-1942
[6]  
Cody N, 2008, Ir Med J, V101, P140
[7]   Screening for hereditary hemochromatosis in siblings and children of affected patients - A cost-effectiveness analysis [J].
El-Serag, HB ;
Inadomi, JM ;
Kowdley, KV .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (04) :261-+
[8]   Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations [J].
Finlay, Esme ;
Stopfer, Jill E. ;
Burlingame, Eric ;
Evans, Katherine Goldfeder ;
Nathanson, Katherine L. ;
Weber, Barbara L. ;
Armstrong, Katrina ;
Rebbeck, Timothy R. ;
Domchek, Susan M. .
GENETIC TESTING, 2008, 12 (01) :81-91
[9]   Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients Clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia [J].
Goldberg, Anne C. ;
Hopkins, Paul N. ;
Toth, Peter P. ;
Ballantyne, Christie M. ;
Rader, Daniel J. ;
Robinson, Jennifer G. ;
Daniels, Stephen R. ;
Gidding, Samuel S. ;
de Ferranti, Sarah D. ;
Ito, Matthew K. ;
McGowan, Mary P. ;
Moriarty, Patrick M. ;
Cromwell, William C. ;
Ross, Joyce L. ;
Ziajka, Paul E. .
JOURNAL OF CLINICAL LIPIDOLOGY, 2011, 5 (03) :S1-S8
[10]  
Habte L, 2014, CISC VIS NETW IND GL